Hadi Tabibi

Dr. Hadi Tabibi


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

24 September 2012 in Hemodialysis International
Verified
Journal Article
Closed access
PDF file
SSSaman Khalatbari Soltani
Saman Khalatbari Soltani
RJRosita Jamaluddin
Rosita Jamaluddin
HTHadi Tabibi
Hadi Tabibi
MYMohd Yusof
Mohd Yusof
BYBarakatun Nisak Mohd Yusof
Barakatun Nisak Mohd Yusof
LRLeila Rahmani
Leila Rahmani

19 January 2015 in Food & Nutrition Research
Verified
Journal Article
Open access
PDF file
GSGolbon Sohrab
Golbon Sohrab
PAPooneh Angoorani
Pooneh Angoorani
MTMaryam Tohidi
Maryam Tohidi
HTHadi Tabibi
Hadi Tabibi
MKMasoud Kimiagar
Masoud Kimiagar
JNJavad Nasrollahzadeh
Javad Nasrollahzadeh
Pomegranate ( Punicagranatum ) juice decreases lipid peroxidation, but has no effect on plasma advanced glycated end-products in adults with type 2 diabetes: a randomized double-blind clinical trial

1 May 2015 in Nutrition
Verified
Journal Article
Closed access
HIHossein Imani
Hossein Imani
HTHadi Tabibi
Hadi Tabibi
INIraj Najafi
Iraj Najafi
SAShahnaz Atabak
Shahnaz Atabak
MHMehdi Hedayati
Mehdi Hedayati
LRLeila Rahmani
Leila Rahmani

26 April 2016 in International Urology and Nephrology
Verified
Journal Article
Closed access
PDF file
MMM. Mirfatahi
M. Mirfatahi
HTHadi Tabibi
Hadi Tabibi
ANA. Nasrollahi
A. Nasrollahi
MHM. Hedayati
M. Hedayati
MTM. Taghizadeh
M. Taghizadeh

1 March 2016 in Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis
Verified
Journal Article
Closed access
PDF file
HTHadi Tabibi
Hadi Tabibi
HIHossein Imani
Hossein Imani
SAShahnaz Atabak
Shahnaz Atabak
INIraj Najafi
Iraj Najafi
MHMehdi Hedayati
Mehdi Hedayati
LRLeila Rahmani
Leila Rahmani
Background: In peritoneal dialysis (PD) patients, one of the major risk factors for cardiovascular disease is lipid abnormalities. This study was designed to investigate the effects of ginger supplementation on serum lipids and lipoproteins in PD patients. Methods: In this randomized, double-blind, placebo-controlled trial, 36 PD patients were randomly assigned to either the ginger or the placebo group. The patients in the ginger group received 1,000 mg ginger daily for 10 weeks, while the placebo group received corresponding placebos. At baseline and at the end of week 10, 7 mL of blood were obtained from each patient after a 12- to 14-hour fast, and serum concentrations of triglyceride, total cholesterol, low density lipoprotein-cholesterol (LDL-C), high density lipoprotein-cholesterol (HDL-C), and lipoprotein (a) [Lp (a)] were measured. Results: Serum triglyceride concentration decreased significantly up to 15% in the ginger group at the end of week 10 compared with baseline ( p < 0.01), and the reduction was significant in comparison with the placebo group ( p < 0.05). There were no significant differences between the 2 groups in mean changes of serum total cholesterol, LDL-C, HDL-C, and Lp (a). Conclusion: This study indicates that daily administration of 1,000 mg ginger reduces serum triglyceride concentration, which is a risk factor for cardiovascular disease, in PD patients.